The global Infertility Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Equipment, Media & Consumables, Accessories, Procedure, Assisted Re Productive Technology, Artificial Insemination, Fertility Surgeries), By Patient (Female, Male), By End-User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes).
The Infertility Market encompasses a range of medical conditions and treatments related to reproductive health, fertility, and assisted reproduction technologies (ART) for couples experiencing difficulty conceiving or achieving pregnancy. This market includes fertility diagnostics, ovulation induction drugs, assisted reproductive techniques (ART) such as in vitro fertilization (IVF) and intrauterine insemination (IUI), and fertility preservation methods. Innovations in infertility focus on personalized treatment plans, reproductive genetics, egg freezing techniques, sperm quality assessment, and advanced reproductive technologies to address infertility causes, improve conception rates, and fulfill the reproductive needs of individuals and couples seeking fertility solutions.
The global Infertility Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Infertility Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Infertility Industry include- Cooper Medical Inc, CooperVision International Holding Company, Ocular Sciences SAS, Research Instruments Ltd, TCC Holdings S.a.r.l.
A significant trend in the Infertility market is the increasing demand for Assisted Reproductive Technologies (ART) to address infertility challenges in couples worldwide. Factors such as delayed childbearing, lifestyle changes, environmental factors, and reproductive health disorders contribute to rising infertility rates, driving the utilization of ART procedures, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). This trend reflects a growing acceptance of ART as a viable option for achieving pregnancy and parenthood, as well as advancements in ART techniques and success rates that offer hope to individuals and couples facing infertility issues.
The market is primarily driven by technological advancements and innovations in reproductive medicine that enhance the efficacy, safety, and accessibility of infertility treatments. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and mitochondrial replacement therapy (MRT) enable clinicians to select viable embryos with higher implantation potential, reduce the risk of genetic disorders, and improve IVF success rates. Additionally, advancements in cryopreservation techniques, embryo culture media, and gamete quality assessment contribute to optimizing fertility preservation options, increasing the chances of successful conception, and expanding the scope of infertility treatments available to patients.
An opportunity in the Infertility market lies in the development and adoption of personalized approaches to infertility treatment that consider individual patient characteristics, preferences, and underlying causes of infertility. By integrating personalized medicine principles, genomic profiling, and biomarker analysis into infertility diagnosis and treatment planning, healthcare providers can tailor treatment strategies to address specific infertility factors, optimize treatment outcomes, and minimize the physical, emotional, and financial burden of infertility treatments on patients and couples. Additionally, there is potential to explore complementary and alternative therapies, lifestyle interventions, and psychosocial support services that complement conventional infertility treatments and enhance overall patient care in the infertility management continuum.
The segment experiencing the fastest growth within the infertility market landscape is Assisted Reproductive Technology (ART). This encompasses a range of techniques aimed at assisting couples in achieving pregnancy when they have been unable to do so through natural means. ART procedures include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT), among others. With advancements in technology, ART has become increasingly accessible and effective, driving its rapid growth. The rising trend of delayed pregnancies due to lifestyle changes and socioeconomic factors has contributed to the escalating demand for ART procedures. Additionally, the growing acceptance and awareness of fertility treatments worldwide further fuel the expansion of this segment. As fertility issues continue to affect individuals and couples globally, ART is anticipated to sustain its rapid growth trajectory, making it a pivotal area within the infertility market.
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Cooper Medical Inc
CooperVision International Holding Company
Ocular Sciences SAS
Research Instruments Ltd
TCC Holdings S.a.r.l
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Infertility Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Infertility Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Infertility Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Infertility Market Size Outlook, $ Million, 2021 to 2030
3.2 Infertility Market Outlook by Type, $ Million, 2021 to 2030
3.3 Infertility Market Outlook by Product, $ Million, 2021 to 2030
3.4 Infertility Market Outlook by Application, $ Million, 2021 to 2030
3.5 Infertility Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Infertility Industry
4.2 Key Market Trends in Infertility Industry
4.3 Potential Opportunities in Infertility Industry
4.4 Key Challenges in Infertility Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Infertility Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Infertility Market Outlook by Segments
7.1 Infertility Market Outlook by Segments, $ Million, 2021- 2030
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
8 North America Infertility Market Analysis and Outlook To 2030
8.1 Introduction to North America Infertility Markets in 2024
8.2 North America Infertility Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Infertility Market size Outlook by Segments, 2021-2030
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
9 Europe Infertility Market Analysis and Outlook To 2030
9.1 Introduction to Europe Infertility Markets in 2024
9.2 Europe Infertility Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Infertility Market Size Outlook by Segments, 2021-2030
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
10 Asia Pacific Infertility Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Infertility Markets in 2024
10.2 Asia Pacific Infertility Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Infertility Market size Outlook by Segments, 2021-2030
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
11 South America Infertility Market Analysis and Outlook To 2030
11.1 Introduction to South America Infertility Markets in 2024
11.2 South America Infertility Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Infertility Market size Outlook by Segments, 2021-2030
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
12 Middle East and Africa Infertility Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Infertility Markets in 2024
12.2 Middle East and Africa Infertility Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Infertility Market size Outlook by Segments, 2021-2030
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Cooper Medical Inc
CooperVision International Holding Company
Ocular Sciences SAS
Research Instruments Ltd
TCC Holdings S.a.r.l
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Equipment
Media & Consumables
Accessories
Procedure
Assisted Re Productive Technology
Artificial Insemination
Fertility Surgeries
By Patient Type
Female
Male
By End-User
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
The global Infertility Market is one of the lucrative growth markets, poised to register a 7.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Cooper Medical Inc, CooperVision International Holding Company, Ocular Sciences SAS, Research Instruments Ltd, TCC Holdings S.a.r.l
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume